Topiramate is effective for migraine prophylaxis in children
Lewis D, Winner P, Saper J, Ness S, Polverejan E, Wang S, et al. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. Pediatrics 2009;123:924-34.
PII: S0022-3476(09)00629-5
doi:10.1016/j.jpeds.2009.06.054
© 2009 Mosby, Inc. All rights reserved.
